BCI-215

• Description:

  BCI-215 causes selective cancer cell cytotoxicity in part through non-redox-mediated activation of MAPK signaling.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  396.3

• Molecular Formula:

  C22H22BrNO

• Notes:

  Research use only, not for human use.

• Receptor:

  Others

• CAS Number:

  1245792-67-9